Table 2. Characteristics of reported cases of aggressive fibromatosis associated with breast implants.

Author	Age	Biomaterial	Tumour size	Interval (years)	Treatment	Results (months)
Jewitt and Mead [8]	54	Saline	3 cm	2	WLE + removal of prosthesis	DFI: 8
Rosen and Ernsbeerger [9]	35	Saline	NR	NR	Excisional Bx + removal of prosthesis	1st recurrence 7 months and 2nd 12 months, DFI:12
Schuh and Radford [10]	41	Silicone	6.5 cm	2	WLE + removal of prosthesis	DFI: 36
Schiller et al [11]	66	Silicone	13 cm	NR	WLE + removal of prosthesis	NR
Dale et al [12]	65	Silicone	13 cm	7	WLE + removal of prosthesis	NR
Crestinu [13]	NR	Silicone	NR	2	WLE + replacement of prosthesis	DFI: 90
Aaron et al [14]	43	Saline	NR	6	WLE + removal of prosthesis + Rt (45 cGy)	Recurrence at 96 months
Vandeweyer and Deraemaecker [15]	45	Silicone	3 cm	3	Excisional Bx + QT + WLE + Removal of prosthesis + HT	DFI: 24
Abraham et al [16]	55	Silicone	6 cm	NR	WLE + replacement of prosthesis + RT	NR
Khanfir et al [17]	52	Saline	8 cm	1.6	WLE + removal of prosthesis	Recurrence 8
Jandali et al [18]	24	Silicone	6 cm	9	WLE + removal of prosthesis	Recurrence 36
Gandolfo et al [19]	22	Silicone	16 cm	2	WLE + removal of prosthesis	NR
Jamshed et al [20]	30	Saline	5.6 cm	3	WLE + removal of prosthesis	DFI: 24
Neuman et al [21]	64 NR 37 28 38 29	Silicone Silicone Silicone Saline Silicone Silicone	6.7 cm 4.5 cm 3.3 cm 11 cm 12 cm 7.4 cm	1.8 2 2.5 2 2 2	WLE + removal of prosthesis	DFI: 40 DFI: 48 DFI: 42 DFI: 36 Recurrence 24 DFI: 92
Chummun et al [7]	34	Silicone	9 cm	2	Excisional Bx + replacement of prosthesis + Qt	DFI: 55
Matrai et al [1]	34	Silicone	4 cm	2	Excisional Bx + removal of prosthesis + HT	DFI: 28
Brown et al [3]	39	Silicone	5 cm	7	WLE + removal of prosthesis	DFI: 24

WLE: Wide Local Excision; NR: Not Reported; Qt: Chemotherapy; HT: Hormone Replacement Therapy; DFI: Disease-Free Interval.